ATOS Steven C Quay buys $10K worth of shares
May 23, 2025, 4:35 AM
0.00%
What does ATOS do
Atossa Therapeutics, based in Seattle, focuses on developing oral (Z)-endoxifen for breast cancer treatment and prevention, having completed four Phase I and two Phase II clinical studies. The company went public on November 8, 2012, and employs 10 people.
Steven C Quay bought 11,239 shares of ATOS on 21 May at $0.88 per share, worth a total of $10K. They now own 13,898 ATOS shares, or a 423% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.